Terug
Ook genoteerd als
MRAAF
OTC
Dagbereik
€ 11,16
€ 11,34
52-Weeksbereik
€ 6,24
€ 14,10
Volume
38.792
50D / 200D Gem.
€ 11,20
/
€ 9,47
Vorige Slotkoers
€ 11,46
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (621 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,2 | 12,3 |
| P/B | 0,0 | 2,9 |
| ROE % | 9,1 | 8,9 |
| Net Margin % | 13,4 | 5,6 |
| Rev Growth 5Y % | 1,7 | 9,2 |
| D/E | 0,0 | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,00
€ 0,00 – € 0,00
|
310000 B | 0 |
| FY2026 |
€ 61,06
€ 58,56 – € 62,98
|
2100 B | 1 |
Belangrijkste Punten
Revenue grew 1,69% annually over 5 years — modest growth
Earnings grew 29,30% over the past year
Debt/Equity of 0,02 — conservative balance sheet
Generating 268,97B in free cash flow
P/E of 0,18 — trading at a low valuation
PEG of 0,60 suggests growth is underpriced
Groei
Revenue Growth (5Y)
1,69%
Revenue (1Y)6,29%
Earnings (1Y)29,30%
FCF Growth (3Y)76,51%
Kwaliteit
Return on Equity
9,10%
ROIC7,94%
Net Margin13,41%
Op. Margin16,04%
Veiligheid
Debt / Equity
0,02
Current Ratio5,42
Interest Coverage58,58
Waardering
P/E Ratio
0,18
P/B Ratio0,02
EV/EBITDA-1,87
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,29% | Revenue Growth (3Y) | 1,66% |
| Earnings Growth (1Y) | 29,30% | Earnings Growth (3Y) | -2,10% |
| Revenue Growth (5Y) | 1,69% | Earnings Growth (5Y) | -0,34% |
| Profitability | |||
| Revenue (TTM) | 1,74T | Net Income (TTM) | 233,82B |
| ROE | 9,10% | ROA | 7,72% |
| Gross Margin | 41,17% | Operating Margin | 16,04% |
| Net Margin | 13,41% | Free Cash Flow (TTM) | 268,97B |
| ROIC | 7,94% | FCF Growth (3Y) | 76,51% |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 5,42 |
| Interest Coverage | 58,58 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 0,18 | P/B Ratio | 0,02 |
| P/S Ratio | 0,02 | PEG Ratio | 0,60 |
| EV/EBITDA | -1,87 | Dividend Yield | 0,02% |
| Market Cap | 41,21B | Enterprise Value | -523,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,74T | 1,64T | 1,69T | 1,81T | 1,63T |
| Net Income | 233,82B | 180,84B | 243,95B | 314,12B | 237,06B |
| EPS (Diluted) | 62,56 | 47,86 | 66,89 | 81,83 | 61,75 |
| Gross Profit | 717,70B | 636,80B | 675,85B | 768,23B | 622,20B |
| Operating Income | 279,70B | 261,10B | 297,89B | 424,06B | 313,24B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,03T | 3,04T | 2,87T | 2,81T | 2,46T |
| Total Liabilities | 448,22B | 482,29B | 498,36B | 564,09B | 540,62B |
| Shareholders' Equity | 2,58T | 2,56T | 2,36T | 2,24T | 1,92T |
| Total Debt | 59,99B | 105,94B | 157,51B | 144,11B | 182,71B |
| Cash & Equivalents | 625,15B | 622,01B | 467,09B | 516,10B | 363,98B |
| Current Assets | 1,50T | 1,50T | 1,40T | 1,45T | 1,18T |
| Current Liabilities | 276,52B | 317,62B | 297,91B | 319,37B | 317,91B |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026